PROVIDER PROFILE · NPI 1609892371

Michael NoonanM.D.

DermatologyTrumbull, CTI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

2,924

Unique beneficiaries

—

Total services

7,312

Distinct HCPCS

Medicare payment

$246K

Peer benchmark

Total Medicare services vs. 185 Dermatology providers in CT — top quintile (cohort median 1,747).

PRESCRIBING · PART D · 2024

Total Rx claims

2,658

Beneficiaries

—

Total drug cost

$69K

Distinct drugs

Brand share

33.2%

Top prescribed drugs

Ciclopirox Olamine855 claims

Triamcinolone Acetonide265 claims

Mupirocin229 claims

Ciclopirox224 claims

Metronidazole210 claims

QUALITY · MIPS · 2024

Final MIPS score

65.6

Quality

31.2

Cost

0.0

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

-1.13%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$3K

Payment records

138

By payment type

Food and Beverage$3K

Education$95

REFERRAL NETWORK

Where Michael Noonan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Pathology Solutions Llc Clinical Laboratory · Eatontown, NJ	230	314
Tamara Handerson Pathology · Greenwich, CT	227	306
Quest Diagnostics Llc Clinical Laboratory · Wallingford, CT	136	316
NORWALK HOSPITAL ASSOCIATION	42	77
HARTFORD HEALTHCARE LABORATORIES	23	46
THE GRIFFIN HOSPITAL	15	19

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history